[Form 4] Ellington Financial Inc. Insider Trading Activity

Rhea-AI Filing Summary

Ronald I. Simon, a director of Ellington Financial Inc. (EFC), reported two transactions in September 2025. On September 10, 2025 he was issued 9,198 common shares under the companys 2017 Equity Incentive Plan at a $0 grant price; those shares remain forfeitable until September 9, 2026. On September 11, 2025 he purchased 5,544 common shares at $13.5599 per share, held in his personal broker retirement account. After these transactions the report lists 80,000 shares beneficially owned, primarily held indirectly in the Simon Family Trust, of which Dr. Simon is a trustee and for which he disclaims beneficial ownership except to the extent of his pecuniary interest.

Positive

• Director purchase of 5,544 shares at $13.5599 increases insider ownership
• Grant of 9,198 shares aligns director compensation with shareholder value via the 2017 Equity Incentive Plan

Negative

• 9,198 granted shares remain forfeitable until September 9, 2026, limiting immediate ownership rights
• Majority of holdings (80,000 shares) are held indirectly via the Simon Family Trust, reducing direct control disclosure

Insights

Corporate Governance Expert

Director received 9,198 restricted shares and bought 5,544 shares at $13.5599.

The 9,198 shares granted on September 10, 2025 are subject to forfeiture until September 9, 2026, indicating they are restricted compensation under the 2017 Equity Incentive Plan. That means voting/transfer rights may be limited until vesting conditions lapse.

The 5,544 share purchase on September 11, 2025 at $13.5599 was made into a retirement account and increases Dr. Simons personal position. Monitor the September 9, 2026 forfeiture/vesting date for changes in beneficial ownership status.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

SIMON RONALD I

(Last) (First) (Middle)

53 FOREST AVE

(Street)

OLD GREENWICH CT 06870

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Ellington Financial Inc. [ EFC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/10/2025		A		9,198(1)	A	$0(1)	74,456	I	By Trust(2)
Common Stock	09/11/2025		P		5,544	A	$13.5599	80,000	I	By Trust(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The 9,198 shares of common stock, $0.001 par value per share (the "Common Shares") remain forfeitable, subject to the reporting person's continued service as a member of the board of directors of Ellington Financial Inc. (the "Company"), until September 9, 2026. The Common Shares were issued pursuant to, and are subject to the terms and conditions of the Company's 2017 Equity Incentive Plan.

2. The 9,198 Common Shares issued to Dr. Simon on September 10, 2025 are held at the transfer agent of the Company. As of the date of issuance, other than the 9,198 shares issued to Dr. Simon and the 8,378 Common Shares that were previously issued to Dr. Simon on December 27, 2024, all of the remaining Common Shares held by Dr. Simon were held in the Simon Family Trust (the "Trust"). Dr. Simon is a trustee of the Trust. Dr. Simon and his wife are the beneficiaries of the Trust. Dr. Simon disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

3. The 5,544 Common Shares purchased by Dr. Simon on September 11, 2025 are held by his personal broker in an investment retirement account. As of the date of purchase, other than 5,544 shares purchased by Dr. Simon, the 9,198 shares granted on September 10, 2025, the 8,378 Common Shares that were previously issued to Dr. Simon on December 27, 2024, all of the remaining Common Shares held by Dr. Simon were held in the Simon Family Trust (the "Trust"). Dr. Simon is a trustee of the Trust. Dr. Simon and his wife are the beneficiaries of the Trust. Dr. Simon disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

Remarks:

	/s/ Alaael-Deen Shilleh, as attorney-in-fact for Ronald I. Simon	10/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did Ellington Financial (EFC) director Ronald I. Simon report?

He was granted 9,198 common shares on September 10, 2025 (forfeitable until September 9, 2026) and purchased 5,544 shares on September 11, 2025 at $13.5599 per share.

How many EFC shares does Ronald I. Simon beneficially own after the reported transactions?

The Form 4 reports 80,000 shares beneficially owned following the transactions.

Are the 9,198 shares fully vested immediately?

No. The 9,198 shares issued on September 10, 2025 remain forfeitable until September 9, 2026 under the companys plan.

Where are the reported shares held?

The 9,198 granted shares are held at the companys transfer agent and the 5,544 purchased shares are held in Dr. Simons personal broker retirement account; other shares are held in the Simon Family Trust.

Does Dr. Simon have indirect ownership through a trust?

Yes. Many remaining shares are held in the Simon Family Trust, where Dr. Simon is a trustee and disclaims beneficial ownership except for his pecuniary interest.